Grisham, Rachel N. http://orcid.org/0000-0002-8631-9324
Chui, M. Herman http://orcid.org/0000-0002-7220-3996
Funding for this research was provided by:
National Cancer Institute (P30-CA008748)
Article History
Accepted: 29 June 2022
First Online: 13 August 2022
Declarations
:
: Dr. Grisham reports personal fees from Clovis, personal fees from Mateon, personal fees from Regeneron, unpaid consulting for Verastem, personal fees from Amgen, personal fees from Medscape, personal fees from Aptitude Health, personal fees from PER, personal fees from Signatera, personal fees from GSK, personal fees from Corcept, and personal fees from Springworks, outside the submitted work. Dr. Chui reports personal fees from Roche, outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.